vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and TRICO BANCSHARES (TCBK). Click either name above to swap in a different company.
TRICO BANCSHARES is the larger business by last-quarter revenue ($109.4M vs $62.1M, roughly 1.8× Cytek Biosciences, Inc.). TRICO BANCSHARES runs the higher net margin — 251.6% vs -70.9%, a 322.6% gap on every dollar of revenue. On growth, TRICO BANCSHARES posted the faster year-over-year revenue change (9.0% vs 8.1%). TRICO BANCSHARES produced more free cash flow last quarter ($127.9M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 5.4%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Trico Bancshares is a U.S.-headquartered regional bank holding company operating Tri Counties Bank. It offers a full range of retail and commercial banking services including deposit products, mortgages, small business loans, and wealth management, primarily serving consumers and SMEs in Northern California.
CTKB vs TCBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $109.4M |
| Net Profit | $-44.1M | $33.6M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 42.6% |
| Net Margin | -70.9% | 251.6% |
| Revenue YoY | 8.1% | 9.0% |
| Net Profit YoY | -557.1% | 15.8% |
| EPS (diluted) | — | $1.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $109.4M | ||
| Q3 25 | $52.3M | $107.6M | ||
| Q2 25 | $45.6M | $103.6M | ||
| Q1 25 | $41.5M | $98.6M | ||
| Q4 24 | $57.5M | $100.4M | ||
| Q3 24 | $51.5M | $99.1M | ||
| Q2 24 | $46.6M | $97.9M | ||
| Q1 24 | $44.9M | $98.5M |
| Q4 25 | $-44.1M | $33.6M | ||
| Q3 25 | $-5.5M | $34.0M | ||
| Q2 25 | $-5.6M | $27.5M | ||
| Q1 25 | $-11.4M | $26.4M | ||
| Q4 24 | $9.6M | $29.0M | ||
| Q3 24 | $941.0K | $29.1M | ||
| Q2 24 | $-10.4M | $29.0M | ||
| Q1 24 | $-6.2M | $27.7M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 42.6% | ||
| Q3 25 | -17.6% | 43.2% | ||
| Q2 25 | -23.3% | 36.5% | ||
| Q1 25 | -36.1% | 35.8% | ||
| Q4 24 | 5.2% | 38.7% | ||
| Q3 24 | -8.2% | 39.8% | ||
| Q2 24 | -18.3% | 40.0% | ||
| Q1 24 | -23.9% | 38.3% |
| Q4 25 | -70.9% | 251.6% | ||
| Q3 25 | -10.5% | 31.6% | ||
| Q2 25 | -12.2% | 26.6% | ||
| Q1 25 | -27.5% | 26.7% | ||
| Q4 24 | 16.8% | 221.4% | ||
| Q3 24 | 1.8% | 29.3% | ||
| Q2 24 | -22.4% | 29.7% | ||
| Q1 24 | -13.8% | 28.2% |
| Q4 25 | — | $1.02 | ||
| Q3 25 | — | $1.04 | ||
| Q2 25 | — | $0.84 | ||
| Q1 25 | — | $0.80 | ||
| Q4 24 | — | $0.88 | ||
| Q3 24 | — | $0.88 | ||
| Q2 24 | — | $0.87 | ||
| Q1 24 | — | $0.83 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $157.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $1.3B |
| Total Assets | $461.5M | $9.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $157.0M | ||
| Q3 25 | $93.3M | $298.8M | ||
| Q2 25 | $75.5M | $314.3M | ||
| Q1 25 | $95.3M | $308.3M | ||
| Q4 24 | $98.7M | $145.0M | ||
| Q3 24 | $162.3M | $320.1M | ||
| Q2 24 | $177.9M | $206.6M | ||
| Q1 24 | $168.8M | $82.8M |
| Q4 25 | $341.7M | $1.3B | ||
| Q3 25 | $378.6M | $1.3B | ||
| Q2 25 | $377.6M | $1.3B | ||
| Q1 25 | $379.6M | $1.3B | ||
| Q4 24 | $395.7M | $1.2B | ||
| Q3 24 | $385.5M | $1.2B | ||
| Q2 24 | $389.1M | $1.2B | ||
| Q1 24 | $392.6M | $1.2B |
| Q4 25 | $461.5M | $9.8B | ||
| Q3 25 | $494.9M | $9.9B | ||
| Q2 25 | $493.3M | $9.9B | ||
| Q1 25 | $482.6M | $9.8B | ||
| Q4 24 | $499.5M | $9.7B | ||
| Q3 24 | $491.2M | $9.8B | ||
| Q2 24 | $483.7M | $9.7B | ||
| Q1 24 | $492.1M | $9.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $133.3M |
| Free Cash FlowOCF − Capex | $-1.8M | $127.9M |
| FCF MarginFCF / Revenue | -2.9% | 116.9% |
| Capex IntensityCapex / Revenue | 1.6% | 4.9% |
| Cash ConversionOCF / Net Profit | — | 3.96× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $222.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $133.3M | ||
| Q3 25 | $-3.9M | $45.1M | ||
| Q2 25 | $108.0K | $29.2M | ||
| Q1 25 | $-125.0K | $24.5M | ||
| Q4 24 | $2.0M | $109.7M | ||
| Q3 24 | $13.2M | $28.6M | ||
| Q2 24 | $6.2M | $31.8M | ||
| Q1 24 | $4.0M | $25.1M |
| Q4 25 | $-1.8M | $127.9M | ||
| Q3 25 | $-4.6M | $43.2M | ||
| Q2 25 | $-1.5M | $28.2M | ||
| Q1 25 | $-974.0K | $22.8M | ||
| Q4 24 | $1.1M | $105.2M | ||
| Q3 24 | $12.2M | $27.3M | ||
| Q2 24 | $5.2M | $30.8M | ||
| Q1 24 | $3.4M | $24.1M |
| Q4 25 | -2.9% | 116.9% | ||
| Q3 25 | -8.7% | 40.2% | ||
| Q2 25 | -3.2% | 27.2% | ||
| Q1 25 | -2.3% | 23.1% | ||
| Q4 24 | 1.9% | 104.8% | ||
| Q3 24 | 23.7% | 27.6% | ||
| Q2 24 | 11.0% | 31.5% | ||
| Q1 24 | 7.6% | 24.4% |
| Q4 25 | 1.6% | 4.9% | ||
| Q3 25 | 1.3% | 1.7% | ||
| Q2 25 | 3.5% | 1.0% | ||
| Q1 25 | 2.0% | 1.7% | ||
| Q4 24 | 1.6% | 4.5% | ||
| Q3 24 | 2.0% | 1.3% | ||
| Q2 24 | 2.3% | 1.0% | ||
| Q1 24 | 1.3% | 1.0% |
| Q4 25 | — | 3.96× | ||
| Q3 25 | — | 1.33× | ||
| Q2 25 | — | 1.06× | ||
| Q1 25 | — | 0.93× | ||
| Q4 24 | 0.21× | 3.78× | ||
| Q3 24 | 14.05× | 0.98× | ||
| Q2 24 | — | 1.10× | ||
| Q1 24 | — | 0.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
TCBK
Segment breakdown not available.
